Columnist Anna Jeter was recently reminded that she's still absorbing lessons from her chronic illness after 25 years of ...

The American Lung Association launched an awareness campaign to accelerate diagnosis and improve treatment of PAH.

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

Winrevair was approved to treat pulmonary arterial hypertension (PAH), a progressive disorder caused by a constriction of ...

The ability to characterize the pulmonary circulation more fully paved the way for many advances. In the 1950s, Dr David ...

When a person’s asthma is severe or isn’t managed well by typical protocols, they may be a good candidate for pulmonary ...

New data suggests clinicians may be slower to recognize sepsis in people with pulmonary arterial hypertension.

The advice to " go with your gut " is ubiquitous but not always on point. For instance, your gut may tell you not to apply ...

Patients continued taking their medications for pulmonary arterial hypertension (PAH) when symptoms appeared to improve, ...

Positive results from a study of Winrevair could help the drugmaker achieve sales growth past top-seller Keytruda’s upcoming ...

Ferrer is using Pulmonary Hypertension Awareness Month to sound the alarm about the shortcomings of the current pathways for ...